If your culture is based on being able to walk down the hall to ask a question, you don’t have much of a culture — or, at least, not much of an intentional culture.
Shipowners and charterers are altering leasing contracts to cope with the multimillion-dollar port fees expected to be imposed by the Trump administration.
Compounded versions could make up as much as 40% of the semaglutide market, said Novo Nordisk CEO Lars Fruergaard Jorgensen on Thursday, but the company hopes to win patients over.
Arbutus is also exiting its corporate headquarters in Pennsylvania and will terminate all in-house scientific research. The company’s focus is now an RNAi asset for hepatitis B.
2024 was a tough year for the biopharma industry, with several companies cutting hundreds or even thousands of employees. Follow along as BioSpace tracks job cuts and restructuring initiatives throughout 2025.
Suzan DelBene, D-Washington, and Terri Sewell, D-Alabama, introduced legislation to prevent Trump from reassigning IRS investigators to immigration enforcement.
The International Auditing and Assurance Standards Board and the International Sustainability Standards Board provided help with adopting their standards.